Regulation 3 Control of prices
Subject to regulation 4, the maximum price which may be charged for the supply for health service purposes of a branded health service medicine of a particular presentation shall not exceed—
(a)
95.5 per cent of the initial price where, in aggregate, the supplies of branded health service medicines made by a manufacturer or supplier to the health service in the year ending 30th September 1999 exceeded £1,000,000, determined by reference to the amounts reimbursed by the Prescription Pricing Authority in respect of that year; and
(b)
in any other case, the initial price of that presentation.